Effect of Erector Spinae (ESP) Block on Opioid Reduction and Enhanced Recovery After Posterior Cervical Spine Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity Health Network, Toronto

About this trial

Patients undergoing spine surgery frequently experience significant pain after surgery. This can limit patient activity and hinder rehabilitation. If inadequately treated, severe pain can result in emotional and psychological distress and ultimately impact long-term function, and increase the risk of developing pain that lasts longer than six months associated with depression, anxiety and disability.

More specifically, Erector Spinae Plane (ESP) block is a recently described plane block designed to block the dorsal and ventral rami of the thoracic spinal nerves. It has shown to be an effective modality for postoperative pain management as a part of multimodal analgesia in spinal surgery.

Eligibility criteria

Qualifiers

None

Disqualifiers

In patients who are allergic to local anesthetics.

ASA IV patients

Lack of informed consent

Pregnant patient.

Trial design

Treatments tested in this trial

  • Erector Spinae (ESP) Block with Lidocaine/Bupivacaine
  • Erector Spinae (ESP) Block with placebo

Treatment groups

52 Participants
are divided into 2 treatment groups